{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:20:06Z","timestamp":1783351206405,"version":"3.54.6"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2026.21753","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:01:30Z","timestamp":1783350090000},"page":"e2621753","source":"Crossref","is-referenced-by-count":0,"title":["Prostate Cancer Screening\u2014Where We\u2019ve Been, Where We Are, and What Comes Next"],"prefix":"10.1001","volume":"9","author":[{"given":"Saira","family":"Khan","sequence":"first","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Langston","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Sutcliffe","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"11","key":"zic260173r1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","article-title":"Prostate cancer, version 3.2026, NCCN Clinical Practice Guidelines in Oncology.","volume":"23","author":"Spratt","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"zic260173r2","article-title":"Prostate-specific antigen screening patterns and metastatic prostate cancer in US veterans.","volume":"9","author":"Siavoshi","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"17","key":"zic260173r3","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening\u2014 23-year follow-up.","volume":"393","author":"Roobol","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"zic260173r4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eururo.2014.12.006","article-title":"Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the G\u00f6teborg randomized population-based prostate cancer screening trial.","volume":"68","author":"Arnsrud Godtman","year":"2015","journal-title":"Eur Urol"},{"issue":"18","key":"zic260173r5","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force.","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zic260173r6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/JU.0000000000001903","article-title":"Factors associated with discontinuation of active surveillance among men with low-risk prostate cancer: a population-based study.","volume":"206","author":"Timilshina","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"zic260173r7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.34295","article-title":"Adherence to a risk-adapted screening strategy for prostate cancer: first results of the PROBASE trial.","volume":"152","author":"Krilaviciute","year":"2023","journal-title":"Int J Cancer"},{"issue":"10438","key":"zic260173r8","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/S0140-6736(24)00912-7","article-title":"Prostate Cancer UK launches the TRANSFORM trial.","volume":"403","author":"Burki","year":"2024","journal-title":"Lancet"},{"key":"zic260173r9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.euros.2024.09.003","article-title":"Risk-stratified approach to implementing population-based prostate cancer screening in five pilot sites in the European Union: a protocol for the PRAISE-U Project.","volume":"70","author":"Chandran","year":"2024","journal-title":"Eur Urol Open Sci"},{"issue":"17","key":"zic260173r10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1001\/jama.2024.3841","article-title":"Prostate cancer screening with PSA, Kallikrein Panel, and MRI: the ProScreen Randomized Trial.","volume":"331","author":"Auvinen","year":"2024","journal-title":"JAMA"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851144\/khan_2026_ic_260173_1782493127.09466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:01:31Z","timestamp":1783350091000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.21753","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]}}}